HERV-K-MEL is a peptide derived from endogenous retroviral protein regions, featuring residues implicated in antigenicity and folding. The sequence supports studies of unusual structural motifs, evolutionary biology, and peptide-MHC interactions. Researchers apply it in structural immunology and biochemical mapping.
CAT No: ta-425
HERV-K-MEL is a synthetic peptide derived from the human endogenous retrovirus K (HERV-K) family, specifically representing an immunogenic region associated with melanoma antigens. As a peptide compound, it embodies a sequence motif relevant to tumor antigenicity and retroviral protein studies. Its biochemical significance lies in its mimicry of naturally occurring epitopes, making it a valuable tool for investigating host-pathogen interactions, immune recognition, and the molecular biology of endogenous retroviral elements. Researchers utilize this peptide to elucidate the functional roles of HERV-K sequences in cellular processes, with particular relevance to cancer biology and immunological research.
Epitope Mapping: HERV-K-MEL is widely used in epitope mapping studies aimed at identifying specific antigenic determinants recognized by immune cells. By providing a defined peptide sequence corresponding to a region of the HERV-K envelope protein, investigators can assess T-cell or antibody responses in various experimental models. Such mapping is crucial for understanding the immunogenic landscape of endogenous retroviruses in cancer and for characterizing the specificity of immune surveillance mechanisms in tumor microenvironments.
Immunological Assays: The peptide serves as a standard reagent in immunological assays, including ELISPOT, ELISA, and flow cytometry-based detection of antigen-specific T cells. Its defined sequence allows for precise stimulation of immune cells, enabling the quantification and functional analysis of HERV-K-directed immune responses. These assays are instrumental in studies of tumor immunology, vaccine development, and the assessment of immune memory related to endogenous retroviral antigens.
Peptide-Based Vaccine Research: HERV-K-MEL is a valuable model antigen in the preclinical evaluation of peptide-based vaccine strategies targeting cancer-associated antigens. By incorporating this peptide into vaccine formulations, researchers can investigate immunogenicity, antigen processing, and presentation pathways. Such studies inform the rational design of experimental immunotherapies that harness the immune system's ability to recognize and target malignancies expressing HERV-K-derived epitopes.
T-Cell Receptor Characterization: In functional studies of T-cell receptor (TCR) specificity, the peptide is employed to stimulate and expand T-cell populations recognizing HERV-K antigens. This application facilitates the isolation and characterization of TCRs with defined specificity, supporting investigations into T-cell repertoire diversity, cross-reactivity, and the development of TCR-engineered cellular models. These insights are critical for advancing adoptive cell transfer approaches and for dissecting the molecular determinants of antigen recognition.
Peptide-Protein Interaction Studies: HERV-K-MEL is utilized in biochemical assays designed to interrogate peptide-protein interactions, particularly those involving major histocompatibility complex (MHC) molecules. By assessing peptide binding and stability within MHC complexes, researchers gain insight into antigen processing and presentation mechanisms relevant to immune surveillance. This application supports the broader understanding of how endogenous retroviral peptides contribute to immune recognition in both healthy and disease contexts.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More